Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Subjects With T1DM

Inclusion Criteria:

- Female or male subjects with T1DM for at least 1 year; diagnostic criteria as defined
by the American Diabetes Association (3).

- Treated with insulin for T1DM for at least 1 year and with stable insulin treatment
(defined as no more than a 10-unit daily variation in total daily insulin dose) 30
days prior to screening

- Hemoglobin A1c <10%.

- Aged between 18 and 75 years, both inclusive.

Exclusion Criteria:

- Previous participation in a clinical trial within the dasiglucagon in the rescue
treatment of hypoglycemia program.

- Known or suspected allergy to trial drug(s) or related products.

- History of anaphylaxis or symptoms of severe systemic allergy (such as angioedema).

- Previous participation in this trial. Participation being defined by signing the
informed consent document.